Update on the in vivo tolerance and in vitro reduced susceptibility to the antimalarial lumefantrine.

Abstract excerpt

Coartem(®), the combination of artemether (an artemisinin derivative) and lumefantrine, has been adopted as the first-line treatment for uncomplicated malaria in many countries. The emergence of resistance to artemisinin derivatives has now been proven in South-East Asia, and there is concern that this may spread to other endemic areas. Strategies to contain and control the spread of artemisinin resistance have...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Asia, Southeastern
• Share to Chloroquine
• Share to Drug Tolerance